Open Access Open Access  Restricted Access Subscription or Fee Access

Cord Blood for Brain Injury: A Synopsis of the Latest Research

Manjit Singh


Cell therapies, especially those that utilization cord blood stem cells; can possibly fundamentally propel the treatment of patients with obtained and genetic brain diseases. The way things are presently, accessible medicines for neurological injuries are unfortunately, limited in scope. Most treatments are limited to supportive or palliative measures went for dealing with the side effects of the conditions as opposed to the basic causes. Recovery is, in this way, regularly deficient and frequently brings about huge and permanent disabilities. These constraints have fueled research into conceivable medicines that could address the hidden causes instead of just the side effects. There is tremendous intrigue and strides are developing stem cell therapies as potential medications to repair damage, regain function and enhance quality of life in patients with neurological disorders. Such therapies represent to a potential sea change in medicines and results.

Full Text:



. Kurtzberg, J.M. Sun. Cord blood for brain injury, Cytotherapy, Int Soc Cell Ther. 2015.

M.L. Escolar, M.D. Poe, J.M. Provenzale, K.C. Richards, J. Allison, S. Wood, et al. Transplantation of umbilical-cord blood in babies with infantile Krabbe’s disease, N Engl J Med. 2005; 352: 2069–81p.

C. Meier, J. Middelanis, B. Wasielewski, S. Neuhoff, A. Roth-Haerer, M. Gantert, et al. Spastic paresis after perinatal brain damage in rats with hemorrhagic brain damage in rats is reduced by human cord blood mononuclear cells. Pediatric Res. 2006; 59: 244–9p.

A.Z. Englander, C.E. Pizoli, A. Batrachenko, J. Sun, G. Worley, M.A. Mikati, et al. Diffuse reduction of white matter connectivity in cerebral palsy with specific vulnerability of long range fiber tracts, Neuroimage Clin. 2013; 2: 440–7p.

S. Ha, Y.H. Suh, K.A. Chang. Therapeutic effects of human adipose-derived stem cells in VPA-induced autism mouse model, Neuroscience. 2013. Poster 50.01/Q57.

N. Xiong, Z. Zhang, J. Huang, C. Chen, M. Jia, J. Xiong, et al. VEGF-expressing human umbilical cord mesenchymal stem cells, an improved therapy strategy for Parkinson’s disease, Gene Ther. 2011; 18: 394–402p.



  • There are currently no refbacks.